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Abstract
Background: Laparoscopic complete mesocolic excision (CME) of the right colon with central vascular ligation (CVL) is a technically
demanding procedure. This study retrospectively evaluated the feasibility, safety and oncological outcomes of the procedure when
performed using the da VinciVR robotic system.
Methods: A prospective case series was collected over 3 years for patients with right colonic cancers treated by standardized robotic
CME with CVL using the superior mesenteric vessels first approach. The CME group was compared to a 2 : 1 propensity score-matched
non-CME group who had conventional laparoscopic right colectomy with D2 nodal dissection. Primary outcomes were total lymph
node harvest and length of specimen. Secondary outcomes were operative time, postoperative complications, and disease-free and
overall survival.
Results: The study included 120 patients (40 in the CME group and 80 in the non-CME group). Lymph node yield was higher (29 versus
18, P¼ 0.006), the specimen length longer (322 versus 260 mm, P¼ 0.001) and median operative time was significantly longer (180 ver-
sus 130 min, P< 0.001) with robotic CME versus laparoscopy, respectively. Duration of hospital stay was longer with robotic CME, al-
though not significantly (median 6 versus 5 days, P¼ 0.088). There were no significant differences in R0 resection rate, complications,
readmission rates and local recurrence. A trend in survival benefit with robotic CME for disease-free (P¼ 0.0581) and overall survival
(P¼ 0.0454) at 3 years was documented.
Conclusion: Robotic CME with CVL is feasible and, although currently associated with a longer operation time, it provides good speci-
men quality, higher lymph node yield and acceptable morbidity, with a disease-free survival advantage.
Introduction
Total mesorectal excision (TME) has resulted in improved local
recurrence rates after Heald’s principles were accepted as the
standard of care1. The concept of complete mesocolic excision
(CME) of colonic cancers has gained variable acceptance across
the surgical community. This is especially true for right colonic
tumours, where the optimal extent and radicality of resection
still remain unclear. Hohenberger applied the basic principles of
total TME to the right colectomy, consisting of preserving the em-
bryological mesocolic plane, dissecting the vessels centrally at
the superior mesenteric artery (SMA) and vein, and extending the
lymphadenectomy along the superior mesenteric vessels (SMV),
including the infrapancreatic and gastroepiploic arcade nodes2.
At least when compared to a historical cohort, lower recurrence
rates and even improved survival were demonstrated3,4. Other
authors independently analysed Erlangen specimens, confirming
that CME surgery results in a higher mesocolic plane rate, with a
greater area of mesentery containing a higher lymph node yield
(LNY) and a larger overall specimen than standard UK and
Danish cancer resection operations5.
However, the Hohenberger procedure includes Kocherization
of the pancreatic head and lymphadenectomy around central
vessels, which markedly increase its complexity. While the
Hohenberger procedure was originally described using an open
approach, modifications have enabled adoption of laparoscopy
and decreased morbidity6,7. Commonly, the Kocherization and
lymphadenectomy beyond the central middle colic vein are omit-
ted. Still, the laparoscopic procedure remains technically chal-
lenging, which raises the question whether robotic surgery may
facilitate adherence to the principles of CME, especially regarding
central vascular ligation (CVL). In addition to conventional
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laparoscopy, the robotic system offers a surgeon-guided stable
camera platform, providing an excellent three-dimensional view,
seven degrees of freedom of the instrumentation, tremor filtering
and individualized ergonomics. While robotic right colectomy
with CME has recently been reported8, there are sparse data
available on robotic CME when it comes to the technical aspects
of central vascular dissection. This report aimed to assess the
technical aspects and short-term and oncological outcomes of
robotic right colectomy with CME and CVL for clinically node-




Consecutive patients who underwent robotic right or extended
right hemicolectomy with CME and CVL were included in this
case series. The data were obtained from a prospectively col-
lected and maintained, ethics committee-approved colorectal
cancer database. Data were retrospectively analysed to assess
the feasibility and safety of robotic right colectomy for tumours
of the right colon. Patients were included if presenting with
tumours of the hepatic flexure and transverse colon, where lym-
phatic drainage was along the right colic or middle colic vessels.
Patients with cN1–2 disease on staging scans and aged 18–70
years were considered suitable for CME right or extended right
hemicolectomy. Radiological criteria for nodal involvement in-
cluded size greater than 10 mm, internal heterogeneity and an ir-
regular border. Patient demographics, intraoperative details and
postoperative outcomes were analysed.
In a subset analysis, the pilot group of CME cases was com-
pared to a 2 : 1 propensity-matched laparoscopic right colectomy
group, where no CVL or central lymphadenectomy was routinely
performed. For propensity score-matching, all patients who
underwent laparoscopic right-sided resections for colonic cancers
at the authors’ institute between 2007 and 2017 were included.
The comparative CME group was operated on between 2014 and
2017.
Outcome measures
The primary outcomes for the study were total lymph node har-
vest and length of specimen. Secondary outcomes were operative
time, postoperative complications (according to Clavien-Dindo
classification), and disease-free (first recurrence after surgical re-
section (DFS)) and overall survival (any cause of death after surgi-
cal resection (OS)).
Pathological examinations of the resected specimens, includ-
ing the number of harvested lymph nodes, were a particular fo-
cus as a surrogate for adequacy of oncological tumour clearance.
Tissue measurements were taken by the pathologists on for-
malin-fixed specimens, and standard histopathology techniques
without ancillary methods were used to assess the number and
involvement of lymph nodes (Fig. 1). Central nodes were not
assessed separately in this study. Patients were followed up with
annual CT scan of chest, abdomen and pelvis for 5 years and a
colonoscopy in the first 3 years after surgery. Recurrences were
diagnosed based on radiology findings on the CT scan and with
tissue biopsy where appropriate along with tumour markers (car-
cinoembryonic antigen). Local recurrences were defined as either
luminal at the site of anastomosis, mesenteric or omental and
peritoneal with carcinomatosis.
Robotic surgical technique
Patients were placed in a modified Lloyd–Davis position and se-
cured on an antislip mattress. Procedures were carried out using
a da VinciVR Si or X robotic surgical system (Intuitive Surgical,
California, USA). Bony landmarks, namely the xiphisternum (XS),
pubic symphysis (PS), costal margins on both sides and both an-
terior superior iliac spines (ASIS), were marked. A midline was
drawn from XS to PS and the midpoint marked. Both ASIS were
connected to the midpoint, forming the spinoumbilical line (SUL)
on both sides. A line was drawn about 8 cm on either side of the
midline, which constituted the midclavicular line (MCL).
• Si System. The optical port was placed about 2 cm to the left
of the midpoint on the midline. The first robotic port (R1) was
marked in the left upper quadrant, 2 cm medial to the left
MCL and 4–6 cm below the left costal margin. This point was
also used for insertion of the Veress needle for creating the
pneumoperitoneum. The second robotic port (R2) was
marked at the point of transection of the right SUL and MCL.
The third robotic port (R3) was marked in the suprapubic
area, 8–10 cm below the optical port. The assistant port was
nearly a mirror image of the R2 on the right side (Fig. 2). The
minimum distance between the ports and the distance from
the camera port should be 8 cm (Fig. 2a).
• X/Xi System. The intersection of the midclavicular line was
joined to the midpoint of the inguinal ligament; on this line,
four robotic ports were placed at least 6 cm apart and at least
3 cm away from the bony landmarks (Fig. 2b). An assistant
port was placed in the left iliac fossa. The camera was placed
in R1 or R2, depending upon the stage of the procedure. The
procedure started with the creation of the pneumoperito-
neum with a Veress needle at the marked site for R4. After
inserting all ports, the patient was placed in a 15
Trendelenburg position and a 15 left tilt.
The first part of the procedure was the laparoscopic set-up,
which includes exposure of the transverse colon by pushing
the omentum over the transverse colon to the upper abdomen.
The small bowel was brought to the left side, exposing the root of
the mesenteric vessels. If necessary, a swab was used to keep the
small bowel loops out of the operating field. The robotic cart was
docked from the right side of the patient midway between the
ASIS and CM.
Dissection started at the root of the SMV pedicle, where the
peritoneal layer covering the mesentery was opened using
monopolar diathermy. The mesenteric fat was dissected to ex-
pose the SMV alongside the SMA. In patients with high BMI the
use of robotic ultrasound probe was standard to identify the ex-
act location of SMV, as previously reported and demonstrated
Video S1. Ileocolic and right colic vessels were ligated at their ori-
gin using robotic hemolock clips. The dissection was continued
cranially and led to the origin of the middle colic vessels. The
middle colic vein was divided at its origin. The middle colic artery
at its origin, or only the right branch, was divided depending
upon the location of the tumour. The Henle’s trunk was dissected
and the colic branch ligated. The right gastroepiploic vein was
dissected of lymphatic tissue or ligated and resected centrally.
Anatomical variations were common at this point, which had to
be considered. Medial to lateral dissection was carried out be-
tween the visceral and parietal peritoneum, exposing the head of
pancreas completely. After performing the subileal, lateral and
hepatic flexure mobilization, the small bowel mesentery and cor-
responding part of the omentum were transected using a robotic
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vessel sealer. The gastrocolic omentum was divided using a ves-
sel sealer, sparing the gastroepiploic arcade. Kocherization of the
duodenum was not performed routinely unless lymphadenopa-
thy was seen in the retropancreatic nodal station on the CT scan.
A bolus of 3 ml indocyanine green was administered intrave-
nously to assess the vascularity of the transresection sites of the
transverse colon and terminal ileum. Three firings of a liner 60
mm stapler were used for transection of the transverse colon, ter-
minal ileum and intracorporeal ileocolic anastomosis. The enter-
otomy was closed with a 3/0 vicryl running suture in two layers,
and the specimen extracted through a Pfannenstiel incision.
Laparoscopic surgical technique
Surgeons had had an established practice for over 5 years and
were trainers in the LapCo training programme. A standard four-
port laparoscopic right colectomy was carried out. Ileocolic, right
colic and middle colic vessels were ligated at origin between the
clips. Routine exposure of SMV was not carried out. D2 lymph
node dissection was carried out with ligation of vessels between
hemolock clips and medial to lateral mobilization of the right
colon. A midline extraction was made and an extracorporeal sta-
pled side-to-side anastomosis was fashioned.
Statistical analysis
To decrease variation in baseline characteristics between robotic
and laparoscopic cases, nearest neighbour 2 : 1 propensity score-
matching without a caliper was applied to minimize selection
bias. In the common sample, co-variables in regression analysis
with method as the binary outcome variable to obtain the pro-
pensity scores were age, sex, ASA grade, BMI and preoperative
TNM stage. Cases from the conventional laparoscopic pool with
the nearest propensity scores to the robotic cases were 2 : 1
matched. A mean standardized difference of the co-variables be-
tween the matched groups of less than 0.25 (IdI¼ 0.25) was con-
sidered a balanced match. Conditional independence of the
outcome from treatment status after controlling for the co-
variables used for matching was assumed. Furthermore, for each
set of values of those co-variables, a positive probability of being
both treated and not treated was assumed (common support)
and tested graphically. Data were expressed as median with
interquartile ranges. Intergroup comparisons were made using a
Mann–Whitney U test for continuous variables or v2 or Fishers
exact test for categorical variables. P < 0.05 was considered sig-
nificant. A time-to-event analysis was performed using the
Kaplan–Meier method. Comparison of the survival and local re-
currence rates between the two surgical methods was analysed
by the log-rank test. All statistical analyses, including propensity
score matching, were performed using SPSSVR Statistics for
Windows, Version 23 (IBM, New York, USA).
Results
Patients
The study population consisted of 40 robotically operated and
282 laparoscopically operated right colectomy cases. Following
propensity score matching 120 patients were included. A total of
40 patients underwent robotic CME (D3 lymphadenectomy) for
right-sided tumours over a 3-year period (21 females; median age
68 (range 34–80) years; median BMI 26 kg/m2) (Table 1). Tumours






Fig. 1 Specimen after complete mesocolic excision surgery for ascending colon cancer










Fig. 2 Robotic complete mesocolic excision (CME) surgery
a Robotic set-up for CME/central vascular ligation right colectomy using Si
System. b Port placement when using the DaVinciVR X system. R1, R2 and R3,
robotic ports; A, assistant port; O, Optical port; CM, costal margin, MCL;
midclavicular line; SUL, spinoumbilical line.
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(18 patients), hepatic flexure (12 patients) and transverse colon
(6 patients). Eighty per cent of patients underwent right hemico-
lectomy and the remaining 20 per cent had extended right hemi-
colectomy. The non-CME, propensity score-matched group
enlisted 80 patients (43 females; median age 71 (37–82) years; me-
dian BMI 28 kg/m2) treated using laparoscopy.
Lymph node harvest
There was a significantly greater increase in LNY in the CME
group (29 versus 18; P¼ 0.006) (Table 2). R0 resection rates and lo-
cal recurrence were similar across both groups; however, there
was a higher distant metastasis rate in the non-CME group (19/80
versus 3/40; P 0.026). The majority of tumours (CME, 77 per cent;
non-CME, 60 per cent) were T3/T4. The use of adjuvant chemo-
therapy was similar between groups (CME, 31 per cent patients;
non-CME, 30 per cent).
The median length of the specimen was significantly longer in
the CME group (322 versus 260 mm; P¼ 0.001). The median small
bowel and large bowel length and distance of tumour from distal
resection margin was 100 (i.q.r. 35–170) mm, 210 (i.q.r. 105–315)
mm and 55 (i.q.r. 35–75) mm, respectively, for the CME group
versus 70 (i.q.r. 30–110) mm, 180 (i.q.r. 95–265) mm and 50 (i.q.r.
30–60) mm for the non-CME group (Table 3).
Intraoperative outcomes
Operative times were longer in the CME group compared to the
non-CME group (180 min versus 130 min, P 0.001) (Table 4).
Similarly, the median duration of stay was longer in the CME
group, but did not reach statistical significance (6 versus 5 days,
P¼ 0.088). Median blood loss was lower in the CME group (10 ml)
than the non-CME group (50 ml; P¼ 0.569). Four patients in the
non-CME group were converted to open surgery due to technical
and oncological reasons; there were no conversions in the CME
group. Plane of surgical excision was not available for the laparo-
scopic cohort; with the implementation of CME programme, how-
ever, the pathologists routinely reported the grade of mesocolic
excision. Over 92 per cent of patients in the CME group had a
mesocolic plane of excision.
Complications and postoperative outcomes
There was no difference in minor (Clavien-Dindo grade I/II) and
major (Clavien-Dindo grade III/IV) complications or readmission
rate between groups (Table 4). In the CME group, one patient had
a radiological leak that did not require reintervention. Minor
complications included wound infection (1 patient), ileus (2
patients) and rectal bleed (3 patients). There was no 30- or 90-day
mortality.
Median duration of hospital stay was longer with robotic CME
group, although this was not significant (median 6 versus 5 days,
P¼ 0.088).
Table 1 Patient characteristics
Characteristic CME, robotic (n¼40)* Non-CME, laparo-
scopic (n¼80)*
P SMD VR
Age† 69 (34–80) 71 (37–82) 0.976‡ 0.700 1.17
Gender 0.897§ 0.99
Male 19 (34) 37 66) 0.056
Female 21 (33) 43 (67) 0.056
ASA 0.094§ 0.93
1 5 (63) 3 (38) 0.135
2 28 (35) 53 (65) 0.132
3 7 (23) 24 (77) 0.197
BMI† 26 (20–37) 28 (19–47) 0.568 0.143 0.84
Preoperative T stage 0.098‡ 4.12
T1/ T2 9 (22) 32(78) 0.554
T3/T4 28 (37) 48 (63) 0.528
* Values in parentheses are percentages unless indicated otherwise; † values are median (i.q.r.). SMD: standardized mean difference; VR: variance ratio, VR
expected range is (0.52;1.92); CME, complete mesocolic excision. ‡ Mann-Whitney U test, §v2 test.
Table 2 Oncological data
CME, robotic (n¼40)* Non-CME, laparoscopic (n¼80)* P
pT stage 0.098‡
T1/T2 9 (23) 32 (40)
T3/T4 31 (78) 48 (60)
N0 25 (63) 46 (58)
N1 5 (13) 22 (28)
N2 10 (25) 12 (15)
Lymph node harvest† 29 (19–60) 18 (8–53) 0.006§#
R0 resection 39 (98) 80 (100) 0.327¶
Adjuvant chemotherapy 13 (33) 24 (30) 0.847¶
Local recurrence 0 5 (6) 0.102‡
Distant recurrence 3 (8) 19 (24) 0.026¶#
* Values in parentheses are percentages unless indicated otherwise; † values are median (i.q.r.). ‡ Fisher’s exact test, § Mann–Whitney U test, ¶ v2 test.
# Statistically significant at 5%. CME, complete mesocolic excision.
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Oncological outcomes
There was a trend towards improved DFS and OS in the CME group
(Figs. 3, 4). The median 3-year DFS and OS were 90 and 99 per cent
for CME and 78 and 90 per cent for the non-CME group.
Discussion
About 15 per cent of cancers confined to the colonic wall will
have metastatic spread to lymph nodes9. A suboptimal lympha-
denectomy, spillage of malignant cells or an R1 resection would
undoubtedly increase the risk of local recurrence. The average
risk of recurrence after colon cancer surgery is around 11
per cent at 5 years after potentially curative surgery, and is con-
sidered highest for hepatic flexure tumours10. The number of
lymph nodes harvested and mesenteric/mesocolic specimen size
increase with CME, as shown in the Erlangen series. In the pre-
sent study, an increased lymph node harvest was demonstrated
in the robotic CME group compared to the standard laparoscopic
right colectomy group, along with an increase in the specimen
size and bulk. The nodal harvest in colorectal surgery is
Table 3 Specimen size
Characteristics CME, robotic (n¼40)* Non-CME, laparoscopic (n¼80)* P
Length of specimen (mm) 322 (300–390) 260 (202–320) <0.001†‡
Length of small bowel removed (mm) 100 (35–170) 70 (30–110) <0.001†‡
Length of colon removed (mm) 210 (105–315) 180 (95–265) <0.001†‡
Distance of tumour from distal
margin
55 (35–75) 50 (30–60) 0.821
* Values are median (i.q.r.). † Mann–Whitney U test. ‡ Statistically significant at 5%. CME, complete mesocolic excision.
Table 4 Intraoperative and postoperative data
CME, robotic (n¼40)* Non-CME, laparoscopic (n¼80) P value
Docking time (min) 8 (5–25) n.a.
Total operating time (min) 180 (128–300) 130 (90–280) <0.001¶
Console time (min) 135 (105–270) n.a.
Blood loss (mm) 10 (0–20) 50 (10–250) 0.569
Conversion† 0 4 (5) 0.186‡
Length of stay (days) 6 (3–14) 5 (2–41) 0.088§
Complications†
Grade III/IV 2 (5) 4 (5) 0.337‡
Grade I/II 4 (10) 10 (13) 0.229‡
Readmission in 30 days† 3 (8) 6 (7) 0.545‡
* Values are median (i.q.r.) except where indicated; † values in parentheses are percentages. ‡ Fisher’s exact test, § Mann–Whitney U test. ¶ Statistically
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Fig. 3 Kaplan–Meier plots of overall survival in complete mesocolic excision (CME) and non-CME cases
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important for staging and therefore decision making for adjuvant
therapy11. Although fewer than 12 lymph nodes have been shown
to be associated with poorer prognosis, no further value has been
reported for a higher number of lymph nodes4. More recently, a
higher number of lymph nodes (more than 28) harvested in CME
were reported to be associated with a better prognosis12. This
may be because a higher LNY could lead to stage migration and
consecutively to more intensive systemic therapy, associated
with a better prognosis.
Shortcomings of conventional laparoscopic surgery found to
be of particular relevance in the treatment of hepatic flexure and
transverse colon cancers were a shorter vascular pedicle length
and lower number of lymph nodes compared to open surgery,
questioning the oncological adequacy5,13. Robotic-assisted CME,
with its better technical capability of radical central lymph node
and vascular dissection, is beneficial in potentially overcoming
these limitations and leading to improved outcomes14. Although
CME/CVL right hemicolectomy can also be achieved by conven-
tional laparoscopy, a high level of laparoscopic expertise is man-
datory to avoid compromise in difficult situations.
Outcomes following colonic cancer resection have been out-
paced by the advancements in multidisciplinary rectal cancer
treatment. International standardization of the surgical tech-
nique15, guided by high-resolution MRI scanning16 and supported
by histopathological quality control, has enabled TME to greatly
reduce local recurrence rates and improve overall survival17. The
embryological anatomical planes that underpin TME principles
extend proximally to include the entire colon3,18. Therefore, CME
surgery should theoretically benefit patients with colonic cancer.
The 3 year DFS and OS in this study was significantly better com-
pared with the non-CME group and compares favourably with
the published literature2,19.
CME surgery comprises two key components: preservation of the
integrity of the visceral mesocolic fascia to reduce the chance of tu-
mour cell dissemination, and CVL. Division of the supplying artery
at its origin ensures that central lymph node groups receiving lymph
from potentially involved pericolic nodes are excised, which may
make the difference between a curative outcome and locoregional
recurrence8. In contrast to mesorectal excision, there is still a lack of
standardization of the CME technique, and the use of different
terminology such as D3 lymphadenectomy, extended lymphadenec-
tomy or radical right colectomy can be confusing19. Radical CME/
CVL right colectomy has not gained widespread popularity due to
the lack of evidence showing improved survival, as well as the po-
tential morbidity resulting in longer hospital stay20. The latter is con-
firmed in this series by the longer median length of stay by 1 day in
the CME group. In this series, however, there were no cases with ma-
jor vascular injury or chylous ascites. In most cases, those complica-
tions can be avoided by choosing a dissection plane in front of the
SMV, while leaving the neurolymphovascular tissue around the
SMA in place. Starting the vascular dissection distally on the SMV is
advisable, as even in case of damage at that level the vein can be
safely ligated when local bleeding control is not otherwise possible.
To facilitate localization of the distal SMV, especially in obese
patients, the use of intraoperative ultrasound, which may further re-
duce the risk of inadvertent vascular injury, was recently reported21.
Laparoscopy is well established for standard right colectomy,
while there is uncertainty regarding its use in CME/CVL surgery.
The robotic approach for CME surgery for colon cancer is attrac-
tive because of its ergonomic advantages18; however, there are
limited data published in this context6. CME with CVL exclusively
for tumours of the hepatic flexure/transverse colon and node-
positive right colonic tumours has not been reported. Purely lapa-
roscopic approaches to radical right colectomy with CME have
been described in the literature22,23. Robotic-assisted surgery has
an advantage of accessing the target organ more precisely and
from angles practically unattainable with laparoscopy. As a per-
sonal choice, an SMV first medial-to-lateral approach was pre-
ferred for dissection during a robotic CME, as it minimizes the
risk of complications and bleeding by early exposure of the retro-
peritoneal structures and ligation of feeding vessels close to their
origin; furthermore, there is less tumour manipulation24.
Limitations of this study include its retrospective nature, as
selection bias may be a considerable confounder, although it has
been minimized by propensity score matching. Furthermore, the
laparoscopically experienced surgeons participating in this series
may still be in their learning curve of robotic CME, and outcomes
may improve further over time with the robotic method. Finally,
two different operations (conventional versus CME/CVL right
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Fig. 4 Kaplan–Meier plots of disease-free survival in complete mesocolic excision (CME) and non-CME cases
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robotic) were compared simultaneously, which compromises the
evidence.
To date, no RCT has been published showing superiority of
CME/CVL in right colonic cancers. Available cohort studies and
meta-analyses suggest improved survival and lower recurrence
rates with CME surgery25,26. However, further evidence is re-
quired to justify implementation of the technique in routine clini-
cal practice25,27. Larger-scale studies and registry data are
necessary before a strong recommendation for a wider adoption
of the technique can be made.
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